0001715819 false 0001715819 2023-07-01 2023-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 1, 2023

 

 

ELECTROMEDICAL TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware Commission File Number 82-2619815
(State or other jurisdiction of
incorporation or organization)		 000-56192 (I.R.S. Employer
Identification Number)

 

16561 N. 92nd Street, Ste. 101

Scottsdale, AZ 85260

 (Address of Principal Executive Offices and Zip Code) 

 

888-880-7888

(Issuer's telephone number)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbols Name of Exchange on Which Registered
COMMON EMED NONE

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Section 5 - Corporate Governance and Management

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On July 1, 2023, Robert L. Hymers, III resigned as an independent director of the Company. There was no disagreement with the Company on any disclosable matter under Item 5.02(a). The company provided Mr. Hymers with a copy of the disclosures made in this Form 8-K before filing and informed Mr. Hymers of the opportunity to furnish a letter addressed to the company as promptly as possible stating whether he agrees with the company’s disclosures in response to this item and, if not, stating the disagreements. Attached as an exhibit is Mr. Hymers letter of resignation, along with his acknowledgment and agreement with the Company’s disclosures in this Form 8-K.

 

Section 9 – Financial Statement and Exhibits

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No.DocumentLocation
   
17Letter of ResignationFiled Herewith

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated July 5, 2023

 

ELECTROMEDICAL TECHNOLOGIES, INC.

 

By:/s/ Matthew Wolfson 

Matthew Wolfson

Chief Executive Officer

(Principal Executive Officer)

 

 

Exhibit 17

 

July 1, 2023

 

RE: Resignation from Electromedical Technologies, Inc.

 

To the Board of Directors:

 

Please accept this letter as formal notice as my resignation as a director of Electromedical Technologies, Inc. effective July 1, 2023.

 

I have reviewed the draft disclosures that the Company intends to make on Form 8-K pertainingto my resignation as it relates to Item 502 and I agree with them.

 

Regards,

 

Robert Hymers

 

 

 

v3.23.2
Cover
Jul. 01, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 01, 2023
Entity File Number 000-56192
Entity Registrant Name ELECTROMEDICAL TECHNOLOGIES, INC.
Entity Central Index Key 0001715819
Entity Tax Identification Number 82-2619815
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 16561 N. 92nd Street
Entity Address, Address Line Two Ste. 101
Entity Address, City or Town Scottsdale
Entity Address, State or Province AZ
Entity Address, Postal Zip Code 85260
City Area Code 888
Local Phone Number 880-7888
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security COMMON
Trading Symbol EMED
Security Exchange Name NONE
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
ElectroMedical Technolog... (PK) (USOTC:EMED)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas ElectroMedical Technolog... (PK).
ElectroMedical Technolog... (PK) (USOTC:EMED)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas ElectroMedical Technolog... (PK).